AU3387195A - Pharmaceutical compositions comprising a dihydrofolate reductase inhibitor and a dihydropteroate synthetase inhibitor - Google Patents

Pharmaceutical compositions comprising a dihydrofolate reductase inhibitor and a dihydropteroate synthetase inhibitor

Info

Publication number
AU3387195A
AU3387195A AU33871/95A AU3387195A AU3387195A AU 3387195 A AU3387195 A AU 3387195A AU 33871/95 A AU33871/95 A AU 33871/95A AU 3387195 A AU3387195 A AU 3387195A AU 3387195 A AU3387195 A AU 3387195A
Authority
AU
Australia
Prior art keywords
inhibitor
pharmaceutical compositions
dihydrofolate reductase
dihydropteroate synthetase
reductase inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33871/95A
Inventor
William Merrick Watkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU3387195A publication Critical patent/AU3387195A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU33871/95A 1994-08-23 1995-08-21 Pharmaceutical compositions comprising a dihydrofolate reductase inhibitor and a dihydropteroate synthetase inhibitor Abandoned AU3387195A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9416973A GB9416973D0 (en) 1994-08-23 1994-08-23 Carbon side chain
GB9416973 1994-08-23
PCT/EP1995/003335 WO1996005841A1 (en) 1994-08-23 1995-08-21 Pharmaceutical compositions comprising a dihydrofolate reductase inhibitor and a dihydropteroate synthetase inhibitor

Publications (1)

Publication Number Publication Date
AU3387195A true AU3387195A (en) 1996-03-14

Family

ID=10760240

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33871/95A Abandoned AU3387195A (en) 1994-08-23 1995-08-21 Pharmaceutical compositions comprising a dihydrofolate reductase inhibitor and a dihydropteroate synthetase inhibitor

Country Status (4)

Country Link
AU (1) AU3387195A (en)
GB (1) GB9416973D0 (en)
WO (1) WO1996005841A1 (en)
ZA (1) ZA957012B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011018742A1 (en) * 2009-08-13 2011-02-17 Csir Triazine derivates for use in the treatment of malaria

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3919214A1 (en) * 1989-06-13 1990-12-20 Thomae Gmbh Dr K New acyl:aminomethyl-pyrimido-thiazine derivs. - useful as enzyme inhibitors in antimalarial medicaments

Also Published As

Publication number Publication date
WO1996005841A1 (en) 1996-02-29
ZA957012B (en) 1996-11-08
GB9416973D0 (en) 1994-10-12

Similar Documents

Publication Publication Date Title
AU5984296A (en) Quinazolines and pharmaceutical compositions
HUP0104258A3 (en) Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
AU5644896A (en) Protease variants and compositions
HUP9900964A3 (en) Protease inhibitors and pharmaceutical compositions containing these compounds
IL122485A0 (en) Arylsulfonylaminobenzene derivatives and pharmaceutical compositions containg the same
AU1219795A (en) Anti-smoke perfumes and compositions
IL128664A (en) Heterocyclic metalloprotease inhibitors and pharmaceutical compositions comprising them
AU1273297A (en) Flame inhibitor composition and use thereof
LT99141A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
HUP9902256A3 (en) Amidino protease inhibitors and pharmaceutical compositions containing them
GB9827391D0 (en) Aldose reductase inhibitors and pharmaceutical compositions
AU2543399A (en) Anticonvulsant drugs and pharmaceutical compositions thereof
ZA967800B (en) Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
IL117247A0 (en) Pharmaceutical compositions comprising protease inhibitors and quinoxalines
HUP9602196A2 (en) Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
IL134538A (en) Lactacystin derivatives and pharmaceutical compositions containing the same
ZA963397B (en) Esters and pharmaceutical compositions
IL155799A0 (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
HUP9903526A3 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
AU5680900A (en) Combination of mtp inhibitors and hmg-coa reductase inhibitors and the use thereof in medicaments
AU3387195A (en) Pharmaceutical compositions comprising a dihydrofolate reductase inhibitor and a dihydropteroate synthetase inhibitor
IL111467A0 (en) Pharmaceutical compositions comprising 7 beta -substituted -4-aza 5 alpha -cholestan-3-ones and 5 alpha reductase 1 inhibitors
AU7681498A (en) Pharmaceutical composition and use thereof
AU6014696A (en) Anti-metastatic and anti-angiogenic pharmaceutical compositions